Nucleoside reverse transcriptase inhibitors (NRTIs)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nucleoside reverse transcriptase inhibitors (NRTIs), covering 2025-10-07 to 2025-10-07. Get the full timeline:
Most recent: Clinical Trial Update: Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study [Phase 1]